Drugs / vCP65
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00000904 | ? → Aug 1999 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | vCP65 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000904 ↗ |
| Known as | ALVAC-RG Rabies Glycoprotein | “ALVAC-RG Rabies Glycoprotein (vCP65)” NCT00000904 ↗ |